An artificial cell is a synthetic construct that mimics the behavior of a living cell. It is created using inorganic or organic materials, including proteins, lipids, polymers, and other molecules. Artificial cells are designed to carry out specific functions, such as producing drugs, generating energy, or storing information. These cells may also be designed to mimic the behavior of natural cells, such as sensing, responding to stimuli, and dividing.

K. Tucker andersen is a retired portfolio manager and securities analyst. Dr. Donald Masters is president and chief executive officer of artificial cell technologies. His thirty-eight year career began as a member of the Harvard-Monsanto Project that led to the development of the biotechnology industry .

Our proprietary technology is based on polymer encapsulation vesicles which we call Artificial Cell Membranes ("ACMs") we have perfectedand patentedtechniques of making these ACMs. Our polymer-based delivery platform enables packaging of mRNAproteinpeptides and/or oligonucleotidesand keeps the payload stable at 4°C .

HEMARINA is the world's first universal oxygen carrier for therapeutic purposes. HEMO2life® medical device containing an oxygen carrier derived from the arenicole sea worm from hemarina. Read more Read more hemarina and chru de breton announce the continuation of a clinical trial to evaluate the efficacy of hemo2life in kidney transplantation .

CytoSeek uses artificial membrane-binding protein technology to deliver the potential of the next generation of cell therapies. The company was founded by professor Adam perriman, doctor tom green, and doctor ben Carter. They developed the technology at the university of Bristol and are now engaged in proof of principle studies for multiple product candidates .

Fluigent was the first company to solve this problem by introducing an innovative technology: pressure pumps. Research lab can use our ready-to-go instruments for a broad range of applications where fluid control is critical. Our team members come from all over the world, have different backgrounds and are passionate about solving exciting challenges every day .

HEMARINA is the first universal oxygen carrier for therapeutic purposes. Hemarina's oxygen carrier is derived from the arenicole sea worm from the breton biotechnology company. The HEMO2life® medical device containing an oxygen carrier from Hemarina, facilitating preservation Read more Read more .

Dolomite was founded in 2005 and now has many thousands of customers in over 50 countries. Our customers include a wide range of major academic institutes, biotechs, start-ups, pharmaceutical companies, manufacturers, petrochemical companies, government institutes .

KaloCyte is poised to deliver ErythroMer, a dried, bio-inspired artificial red blood cell, to market. The product is envisioned for use when stored red blood cells are unavailable, undesirable or in short supply. It will be available

Xen.AI, is an Artificial Intelligence (AI) research and development organization with operations in USA and india. We help our customers to develop innovative, customized solutions and transform their operations using AI, Machine Learning, Deep Learning, Data Science and Open Source technologies. Our vision is to empower our customers with their digital transformation using artificial intelligence (AI), data science and open source technologies. our team - Great people behind great things!

Search and
explore companies

Artificial Cell

For more optimized search results,
use multiple english keywords and apply filters

Search and explore companies

Company size

Location